GENETIC TECHNOLOGIES LIMITED - Announcements

0.00%

3.9¢

Market Cap $52.08M

Healthcare Medical Care

Genetic Technologies Limited is an Australia-based diversified molecular diagnostics... Genetic Technologies Limited is an Australia-based diversified molecular diagnostics company. The Company is engaged in providing genomics-based tests on health, wellness and serious disease through its EasyDNA brand. The Company offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The Company has a proprietary risk stratification platform that integrates clinical and genetic risk to deliver outcomes to physicians and individuals. The Company's segments include EasyDNA and AffinityDNA. EasyDNA segment relates to EasyDNA branded test sales and expenses. AffinityDNA segment relates to AffinityDNA branded test sales and expenses.More

RCE'S BREAKTHROUGH

Recce Pharmaceuticals (ASX:RCE) accelerates commercialisation with positive Phase II results.

Announcements

Filter Results

All Price Sensitive Only

GTG	Long Term Suspended Entities	PRICE SENSITIVE	16/07/25	262.84KB	Share
GTG	Change of Auditor		30/06/25	98.82KB	Share
GTG	Binding Term Sheets Executed	PRICE SENSITIVE	06/06/25	137.05KB	Share
GTG	Notification of cessation of securities - GTG		23/05/25	12.63KB	Share
GTG	Notification of cessation of securities - GTG		23/05/25	12.71KB	Share
GTG	Change in substantial holding		22/05/25	339.83KB	Share
GTG	Becoming a substantial holder		21/05/25	382.49KB	Share
GTG	Initial Director's Interest Notice x2		21/05/25	246.84KB	Share
GTG	Application for quotation of securities - GTG		21/05/25	15.45KB	Share
GTG	Application for quotation of securities - GTG		21/05/25	15.45KB	Share
GTG	Change of Registered Office Address		15/05/25	101.26KB	Share
GTG	Final Director's Interest Notice		15/05/25	220.1KB	Share
GTG	Update on Board and Executive Changes	PRICE SENSITIVE	15/05/25	103.86KB	Share
GTG	Effectuation of Deed of Company Arrangement	PRICE SENSITIVE	14/05/25	188.23KB	Share
GTG	Initial Director's Interest Notice x2		14/05/25	235.22KB	Share
GTG	Final Director's Interest Notice x 3		14/05/25	274.44KB	Share
GTG	Proposed issue of securities - GTG		14/05/25	13.85KB	Share
GTG	Proposed issue of securities - GTG		14/05/25	13.89KB	Share
GTG	Director Appointment/Resignation		14/05/25	98.65KB	Share
GTG	Results of General Meeting		14/05/25	124.7KB	Share
GTG	Notice of General Meeting		16/04/25	1.3MB	Share
GTG	Long Term Suspended Entities	PRICE SENSITIVE	09/04/25	204.98KB	Share
GTG	Letter to Shareholders		24/03/25	163.42KB	Share
GTG	Creditors resolve to execute Benelong DOCA		28/02/25	160.58KB	Share
GTG	Change of registered office address		24/02/25	72.16KB	Share
GTG	Resumption of Reconvened Meeting of Creditors		21/02/25	180.55KB	Share
GTG	Notice of Reconvened Second Meeting of Creditors		13/02/25	184.53KB	Share
GTG	Notice of Reconvened Second Meeting of Creditors		05/02/25	181.35KB	Share
GTG	Long Term Suspended Entities	PRICE SENSITIVE	22/01/25	201.08KB	Share
GTG	GTG sells Affinity/EasyDNA businesses	PRICE SENSITIVE	20/01/25	95.5KB	Share
GTG	Agreement to sell EasyDNA and AffinityDNA		15/01/25	99.12KB	Share
GTG	GTG completes sale of geneType business and assets		24/12/24	79.2KB	Share
GTG	RHY: RHY Acquires Genetype Genetic Risk Assessment Business	PRICE SENSITIVE	23/12/24	519.3KB	Share
GTG	Second Creditors' Meeting called by Administrators		13/12/24	182.74KB	Share
GTG	Notice of Delisting from Nasdaq		13/12/24	82.61KB	Share
GTG	Deferral relief		02/12/24	148.03KB	Share
GTG	Response to ASX Query	PRICE SENSITIVE	29/11/24	452.58KB	Share
GTG	Cancel - Proposed issue of securities - GTG		27/11/24	24.55KB	Share
GTG	Entitlement Offer Update - Refund of Application Monies		26/11/24	171.54KB	Share
GTG	Continuation of Suspension from Quotation	PRICE SENSITIVE	22/11/24	109.56KB	Share
GTG	Appointment of Voluntary Administrators	PRICE SENSITIVE	20/11/24	166.56KB	Share
GTG	Change of registered address		12/11/24	101.03KB	Share
GTG	Update - Proposed issue of securities - GTG		01/11/24	24.58KB	Share
GTG	Update - Proposed issue of securities - GTG		01/11/24	24.55KB	Share
GTG	Extend Entitlement Offer closing date & voluntary suspension		01/11/24	317.05KB	Share
GTG	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/10/24	391.41KB	Share
GTG	Extension of voluntary suspension		24/10/24	103.09KB	Share
GTG	Voluntary Suspension	PRICE SENSITIVE	21/10/24	198.88KB	Share
GTG	Trading Halt	PRICE SENSITIVE	17/10/24	197.61KB	Share
GTG	Update - Receipt of R&D Tax Incentive Refund		08/10/24	97.93KB	Share
GTG	Receipt of R&D Tax Incentive Refund		03/10/24	94.34KB	Share
GTG	Investor webinar presentation		02/10/24	106.5KB	Share
GTG	Appendix 4G		30/09/24	290.24KB	Share
GTG	Corporate Governance Statement		30/09/24	323.56KB	Share
GTG	Annual Report to shareholders		30/09/24	5.08MB	Share
GTG	Update - Proposed issue of securities - GTG		17/09/24	24.69KB	Share
GTG	Security Class Suspension from Quotation GTGN	PRICE SENSITIVE	16/09/24	419.88KB	Share
GTG	Entitlement Offer Results and Closing	PRICE SENSITIVE	11/09/24	183.26KB	Share
GTG	GTG invited to join prestigious CancerIQ platform	PRICE SENSITIVE	11/09/24	175.87KB	Share
GTG	FY24 results announcement and operations update	PRICE SENSITIVE	30/08/24	167.67KB	Share
GTG	Preliminary Final Report	PRICE SENSITIVE	30/08/24	847.04KB	Share
GTG	Update - Proposed issue of securities - GTG		28/08/24	24.58KB	Share
GTG	Non-Renounceable Issue extension of Closing Date		28/08/24	121.46KB	Share
GTG	Global launch of geneType on EasyDNA platform	PRICE SENSITIVE	15/08/24	90.15KB	Share
GTG	Ineligible shareholders letter		12/08/24	174.22KB	Share
GTG	Eligible shareholders access letter		12/08/24	218.31KB	Share
GTG	Entitlement Offer Prospectus	PRICE SENSITIVE	02/08/24	979.04KB	Share
GTG	Lodgement of Prospectus - Non-renounceable Entitlement Offer		02/08/24	175.63KB	Share
GTG	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/07/24	385.52KB	Share
GTG	Proposed issue of securities - GTG		26/07/24	24.76KB	Share
GTG	Strategic restructure to focus on USA sales growth	PRICE SENSITIVE	26/07/24	203.66KB	Share
GTG	Change in substantial holding		19/07/24	459.24KB	Share
GTG	Change in substantial holding		18/07/24	461.18KB	Share
GTG	S708A Cleansing Notice		16/07/24	126.2KB	Share
GTG	Application for quotation of securities - GTG		16/07/24	15.54KB	Share
GTG	Appointment of CFO and Company Secretary		16/07/24	162.75KB	Share
GTG	Change in substantial holding		12/07/24	454.84KB	Share
GTG	GeneType to Enter Canadian and New Zealand Markets	PRICE SENSITIVE	09/07/24	101.83KB	Share
GTG	Resignation of CFO and Company Secretary		28/06/24	177.01KB	Share
GTG	Business Update - June 2024		28/06/24	3.2MB	Share
GTG	GeneType identifies 79.5% at risk of serious disease	PRICE SENSITIVE	25/06/24	269.36KB	Share
GTG	Change in substantial holding		24/06/24	475.56KB	Share
GTG	GTG Live Investor Webinar and Q&A - June 27		21/06/24	199.54KB	Share
GTG	GTG Expands Operational Capacity in North America	PRICE SENSITIVE	18/06/24	140.32KB	Share
GTG	Notification regarding unquoted securities - GTG		12/06/24	14.41KB	Share
GTG	GeneType and Stayhealthy Announce Landmark Distribution Agre	PRICE SENSITIVE	05/06/24	224.37KB	Share
GTG	Change in substantial holding		05/06/24	531.19KB	Share
GTG	Launch of test for 100% risk of breast and ovarian cancer	PRICE SENSITIVE	29/05/24	228.55KB	Share
GTG	Form F-1 Registration Statement		20/05/24	412.55KB	Share
GTG	GTG and Wellworks for You sign B2B sales and marketing deal	PRICE SENSITIVE	06/05/24	245.19KB	Share
GTG	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/04/24	331.33KB	Share
GTG	Change in substantial holding		24/04/24	483.53KB	Share
GTG	Notification regarding unquoted securities - GTG		23/04/24	14.55KB	Share
GTG	Prospectus Supplement	PRICE SENSITIVE	23/04/24	453.09KB	Share
GTG	GTG announces closing of US$2M Registered Direct Offering		23/04/24	96.03KB	Share
GTG	S708A Cleansing Notice		22/04/24	87KB	Share
GTG	Application for quotation of securities - GTG		22/04/24	15.62KB	Share
GTG	Proposed issue of securities - GTG		22/04/24	15.96KB	Share
GTG	Proposed issue of securities - GTG		19/04/24	16.45KB	Share
GTG	GTG announces US$2 Million Registered Direct Offering	PRICE SENSITIVE	19/04/24	95.75KB	Share

GTG Long Term Suspended Entities
16/07/25	PRICE SENSITIVE	262.84KB	Share
GTG Change of Auditor
30/06/25		98.82KB	Share
GTG Binding Term Sheets Executed
06/06/25	PRICE SENSITIVE	137.05KB	Share
GTG Notification of cessation of securities - GTG
23/05/25		12.63KB	Share
GTG Notification of cessation of securities - GTG
23/05/25		12.71KB	Share
GTG Change in substantial holding
22/05/25		339.83KB	Share
GTG Becoming a substantial holder
21/05/25		382.49KB	Share
GTG Initial Director's Interest Notice x2
21/05/25		246.84KB	Share
GTG Application for quotation of securities - GTG
21/05/25		15.45KB	Share
GTG Application for quotation of securities - GTG
21/05/25		15.45KB	Share
GTG Change of Registered Office Address
15/05/25		101.26KB	Share
GTG Final Director's Interest Notice
15/05/25		220.1KB	Share
GTG Update on Board and Executive Changes
15/05/25	PRICE SENSITIVE	103.86KB	Share
GTG Effectuation of Deed of Company Arrangement
14/05/25	PRICE SENSITIVE	188.23KB	Share
GTG Initial Director's Interest Notice x2
14/05/25		235.22KB	Share
GTG Final Director's Interest Notice x 3
14/05/25		274.44KB	Share
GTG Proposed issue of securities - GTG
14/05/25		13.85KB	Share
GTG Proposed issue of securities - GTG
14/05/25		13.89KB	Share
GTG Director Appointment/Resignation
14/05/25		98.65KB	Share
GTG Results of General Meeting
14/05/25		124.7KB	Share
GTG Notice of General Meeting
16/04/25		1.3MB	Share
GTG Long Term Suspended Entities
09/04/25	PRICE SENSITIVE	204.98KB	Share
GTG Letter to Shareholders
24/03/25		163.42KB	Share
GTG Creditors resolve to execute Benelong DOCA
28/02/25		160.58KB	Share
GTG Change of registered office address
24/02/25		72.16KB	Share
GTG Resumption of Reconvened Meeting of Creditors
21/02/25		180.55KB	Share
GTG Notice of Reconvened Second Meeting of Creditors
13/02/25		184.53KB	Share
GTG Notice of Reconvened Second Meeting of Creditors
05/02/25		181.35KB	Share
GTG Long Term Suspended Entities
22/01/25	PRICE SENSITIVE	201.08KB	Share
GTG GTG sells Affinity/EasyDNA businesses
20/01/25	PRICE SENSITIVE	95.5KB	Share
GTG Agreement to sell EasyDNA and AffinityDNA
15/01/25		99.12KB	Share
GTG GTG completes sale of geneType business and assets
24/12/24		79.2KB	Share
GTG RHY: RHY Acquires Genetype Genetic Risk Assessment Business
23/12/24	PRICE SENSITIVE	519.3KB	Share
GTG Second Creditors' Meeting called by Administrators
13/12/24		182.74KB	Share
GTG Notice of Delisting from Nasdaq
13/12/24		82.61KB	Share
GTG Deferral relief
02/12/24		148.03KB	Share
GTG Response to ASX Query
29/11/24	PRICE SENSITIVE	452.58KB	Share
GTG Cancel - Proposed issue of securities - GTG
27/11/24		24.55KB	Share
GTG Entitlement Offer Update - Refund of Application Monies
26/11/24		171.54KB	Share
GTG Continuation of Suspension from Quotation
22/11/24	PRICE SENSITIVE	109.56KB	Share
GTG Appointment of Voluntary Administrators
20/11/24	PRICE SENSITIVE	166.56KB	Share
GTG Change of registered address
12/11/24		101.03KB	Share
GTG Update - Proposed issue of securities - GTG
01/11/24		24.58KB	Share
GTG Update - Proposed issue of securities - GTG
01/11/24		24.55KB	Share
GTG Extend Entitlement Offer closing date & voluntary suspension
01/11/24		317.05KB	Share
GTG Quarterly Activities/Appendix 4C Cash Flow Report
31/10/24	PRICE SENSITIVE	391.41KB	Share
GTG Extension of voluntary suspension
24/10/24		103.09KB	Share
GTG Voluntary Suspension
21/10/24	PRICE SENSITIVE	198.88KB	Share
GTG Trading Halt
17/10/24	PRICE SENSITIVE	197.61KB	Share
GTG Update - Receipt of R&D Tax Incentive Refund
08/10/24		97.93KB	Share
GTG Receipt of R&D Tax Incentive Refund
03/10/24		94.34KB	Share
GTG Investor webinar presentation
02/10/24		106.5KB	Share
GTG Appendix 4G
30/09/24		290.24KB	Share
GTG Corporate Governance Statement
30/09/24		323.56KB	Share
GTG Annual Report to shareholders
30/09/24		5.08MB	Share
GTG Update - Proposed issue of securities - GTG
17/09/24		24.69KB	Share
GTG Security Class Suspension from Quotation GTGN
16/09/24	PRICE SENSITIVE	419.88KB	Share
GTG Entitlement Offer Results and Closing
11/09/24	PRICE SENSITIVE	183.26KB	Share
GTG GTG invited to join prestigious CancerIQ platform
11/09/24	PRICE SENSITIVE	175.87KB	Share
GTG FY24 results announcement and operations update
30/08/24	PRICE SENSITIVE	167.67KB	Share
GTG Preliminary Final Report
30/08/24	PRICE SENSITIVE	847.04KB	Share
GTG Update - Proposed issue of securities - GTG
28/08/24		24.58KB	Share
GTG Non-Renounceable Issue extension of Closing Date
28/08/24		121.46KB	Share
GTG Global launch of geneType on EasyDNA platform
15/08/24	PRICE SENSITIVE	90.15KB	Share
GTG Ineligible shareholders letter
12/08/24		174.22KB	Share
GTG Eligible shareholders access letter
12/08/24		218.31KB	Share
GTG Entitlement Offer Prospectus
02/08/24	PRICE SENSITIVE	979.04KB	Share
GTG Lodgement of Prospectus - Non-renounceable Entitlement Offer
02/08/24		175.63KB	Share
GTG Quarterly Activities/Appendix 4C Cash Flow Report
31/07/24	PRICE SENSITIVE	385.52KB	Share
GTG Proposed issue of securities - GTG
26/07/24		24.76KB	Share
GTG Strategic restructure to focus on USA sales growth
26/07/24	PRICE SENSITIVE	203.66KB	Share
GTG Change in substantial holding
19/07/24		459.24KB	Share
GTG Change in substantial holding
18/07/24		461.18KB	Share
GTG S708A Cleansing Notice
16/07/24		126.2KB	Share
GTG Application for quotation of securities - GTG
16/07/24		15.54KB	Share
GTG Appointment of CFO and Company Secretary
16/07/24		162.75KB	Share
GTG Change in substantial holding
12/07/24		454.84KB	Share
GTG GeneType to Enter Canadian and New Zealand Markets
09/07/24	PRICE SENSITIVE	101.83KB	Share
GTG Resignation of CFO and Company Secretary
28/06/24		177.01KB	Share
GTG Business Update - June 2024
28/06/24		3.2MB	Share
GTG GeneType identifies 79.5% at risk of serious disease
25/06/24	PRICE SENSITIVE	269.36KB	Share
GTG Change in substantial holding
24/06/24		475.56KB	Share
GTG GTG Live Investor Webinar and Q&A - June 27
21/06/24		199.54KB	Share
GTG GTG Expands Operational Capacity in North America
18/06/24	PRICE SENSITIVE	140.32KB	Share
GTG Notification regarding unquoted securities - GTG
12/06/24		14.41KB	Share
GTG GeneType and Stayhealthy Announce Landmark Distribution Agre
05/06/24	PRICE SENSITIVE	224.37KB	Share
GTG Change in substantial holding
05/06/24		531.19KB	Share
GTG Launch of test for 100% risk of breast and ovarian cancer
29/05/24	PRICE SENSITIVE	228.55KB	Share
GTG Form F-1 Registration Statement
20/05/24		412.55KB	Share
GTG GTG and Wellworks for You sign B2B sales and marketing deal
06/05/24	PRICE SENSITIVE	245.19KB	Share
GTG Quarterly Activities/Appendix 4C Cash Flow Report
30/04/24	PRICE SENSITIVE	331.33KB	Share
GTG Change in substantial holding
24/04/24		483.53KB	Share
GTG Notification regarding unquoted securities - GTG
23/04/24		14.55KB	Share
GTG Prospectus Supplement
23/04/24	PRICE SENSITIVE	453.09KB	Share
GTG GTG announces closing of US$2M Registered Direct Offering
23/04/24		96.03KB	Share
GTG S708A Cleansing Notice
22/04/24		87KB	Share
GTG Application for quotation of securities - GTG
22/04/24		15.62KB	Share
GTG Proposed issue of securities - GTG
22/04/24		15.96KB	Share
GTG Proposed issue of securities - GTG
19/04/24		16.45KB	Share
GTG GTG announces US$2 Million Registered Direct Offering
19/04/24	PRICE SENSITIVE	95.75KB	Share

REFRESH

1 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 3.9¢		Change 0.000(0.00%)		Mkt cap ! $52.08M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

GTG (ASX) Chart

Day chart unavailable

GENETIC TECHNOLOGIES LIMITED - Announcements

Announcements

Top Stories